Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

US-based Hysun Forays Into India Market With Phyto Biotech

US-based Hysun Inc, a biotechnology company on Friday (11 December) has launched its diabetic supplement 'Suga Balanz' in collaboration with Phyto Biotech, Biotechnology company, to tackle root cause of diabetes.

Photo Credit :

1449831762_6iy2JI_Phyto-Biotech-Pvt-Ltd.jpg

US-based Hysun Inc, a biotechnology company on Friday (11 December) has launched its diabetic supplement 'Suga Balanz' in collaboration with Phyto Biotech, Biotechnology company, to tackle root cause of diabetes.

Phyto Biotech to manufacture & sell the product with an initial capacity of 1M Bottles. The product Suga Balanz is already available at all Lifespan clinics, sugabalanz.com, diabetesindiastore.com, healthkart.com and shopclues.com.

Dr Samuel Yue, Founder, Hysun Biomedical Inc, said, “With the launch of our maiden product, we look forward to make a significant contribution to the growing healthcare industry in India. We see huge market potential here, given the large number of diabetic & pre-diabetic people in the country. We believe that diabetes can be better managed if we address the root cause of the problem, which our product Suga Balanz has successfully done for a number of patients globally.” CirQ-Life, the brand of Hy-sun Biomedical, was awarded Mediazone’s most valuable companies in Hong Kong for this year.

Hysun Inc and Phyto Biotech have plans to invest about $15 million in the inital phase of the manufacturing under the 'Make In India' policy.

Karan Kakkad, Director Marketing, Phyto Biotech Pvt Ltd, said “Suga Balanz which was being manufactured only in US, will now be manufactured in India also. The manufactured product will be made available in India and will also be exported to global markets. The lower manufacturing cost will make it more viable for some of the global price sensitive market. ”.

Companay said, that it will launch more than 10 products in the coming years.


Tags assigned to this article:
healthcare Hysun Phyto Biotech diabetics
sentifi.com

Top themes and market attention on: